Molecule to Market: Inside the outsourcing space
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
- Update frequency
- every 6 days
- Average duration
- 45 minutes
- Episodes
- 235
- Years Active
- 2020 - 2025
Pharma services market sentiment at the midpoint of 25
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting.
Your host, R…
Doc to CEO - 40 years of reinvention in biopharma
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stephen Dilly, Chairman, President and Chief Executive Officer at Codexis.
You…
Meet the new boss of CPHI Europe
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tara Dougal, Event Director - Pharma (CPHI Europe).
Your host, Raman Sehgal, d…
30 years on the rollercoaster of clinical trials
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Riches, Vice President, Clinical Solutions at Citeline.
Your host, Rama…
The rain-making, 2X exit founder
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andrea Wagner, CEO at PharmaPhixx.
Your host, Raman Sehgal, discusses the phar…
The Indian CEO driving change
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ankit Gupta, CEO at Tenshi Kaizen.
Your host, Raman Sehgal, discusses the phar…
40 years, 6 exits - a CEO addict
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Sherlock, CEO at Qinecsa.
Your host, Raman Sehgal, discusses the pharmace…
CDMO Live insights: Industry leaders on the future of pharma
In this special episode of Molecule to Market, recorded at this year’s CDMO Live in Rotterdam, industry leaders come together to assess the evolving state of the contract development and manufacturin…
The learning curve of a biotech founder/CSO
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hella Kohlhof, CSO at Immunic.
Your host, Raman Sehgal, discusses the pharmace…
The cancer Doc, driven by impact
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Showalter, Radiation Oncologist, Founder and Chief Medical Officer at Arte…
The GM focused on inhaled & nasal drugs
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gemma Budd, General Manager at Nanopharm.
Your host, Raman Sehgal, discusses t…
The impact of a CEO who loves to work
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeanne Taylor Hecht, Chief Executive Officer and Chairwoman at Lexitas.
Your h…
From brink of bankruptcy to boom
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Garren Hillow, Executive Coach and Author.
Your host, Raman Sehgal, discusses …
The CEO addicted to challenge
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Angelo Gatto, CEO at Chanelle Pharma.
Your host, Raman Sehgal, discusses the p…
The COO leveraging the ‘power of we’
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Christiane Bardroff, COO of Rentschler Biopharma SE.
Your host, Raman Sehgal, …
The pharma CEO focused on US commercial growth
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adriana Herrera, CEO at Pierre Fabre Pharmaceuticals (USA).
Your host, Raman S…
The Spanish solid state specialist
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Victor Diaz, Co-Founder of Solitek.
Your host, Raman Sehgal, discusses the pha…
The bullish CDMO CEO making bold moves
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeremie Trochu, CEO at Ardena.
Your host, Raman Sehgal, discusses the pharmace…
Geordie lad done good in pharma
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Rob Wood, pharma portfolio investor and Founder.
Your host, Raman Sehgal, disc…
The CEO driven by lentiviral vector success
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jon Alberdi, CEO at VIVEbiotech.
Your host, Raman Sehgal, discusses the pharma…